| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
2,137 |
2,034 |
$10.25M |
| J2350 |
Injection, ocrelizumab, 1 mg |
365 |
336 |
$8.65M |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
4,484 |
2,608 |
$4.92M |
| 99233 |
Prolong inpt eval add15 m |
90,873 |
31,204 |
$4.56M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
3,174 |
1,742 |
$3.93M |
| J2323 |
Injection, natalizumab, 1 mg |
564 |
530 |
$2.74M |
| J2357 |
Injection, omalizumab, 5 mg |
1,534 |
1,110 |
$2.34M |
| J2182 |
Injection, mepolizumab, 1 mg |
641 |
597 |
$1.41M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
33,420 |
14,748 |
$1.21M |
| 99223 |
Prolong inpt eval add15 m |
8,929 |
8,568 |
$847K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
726 |
425 |
$728K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,871 |
7,967 |
$553K |
| 99255 |
|
4,930 |
4,561 |
$532K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
18,698 |
5,788 |
$482K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
135 |
76 |
$425K |
| 99222 |
Initial hospital care, per day, moderate complexity |
2,485 |
2,437 |
$175K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,312 |
2,111 |
$141K |
| 96415 |
|
6,557 |
5,939 |
$105K |
| 99254 |
|
1,183 |
1,149 |
$100K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,067 |
909 |
$43K |
| J1335 |
Injection, ertapenem sodium, 500 mg |
1,370 |
138 |
$41K |
| 99215 |
Prolong outpt/office vis |
372 |
323 |
$32K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,832 |
2,399 |
$30K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,353 |
893 |
$30K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,411 |
916 |
$21K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,395 |
2,004 |
$18K |
| 96401 |
|
704 |
634 |
$18K |
| J0878 |
Injection, daptomycin, 1 mg |
278 |
26 |
$14K |
| 36415 |
Collection of venous blood by venipuncture |
2,308 |
1,779 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
70 |
69 |
$6K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
172 |
112 |
$4K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
67 |
51 |
$817.03 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,236 |
1,064 |
$716.21 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
149 |
136 |
$586.96 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
93 |
84 |
$538.47 |